Your browser doesn't support javascript.
loading
The State of the Science on Prostate Cancer Biomarkers: The San Francisco Consensus Statement.
Cooperberg, Matthew R; Carroll, Peter R; Dall'Era, Marc A; Davies, Benjamin J; Davis, John W; Eggener, Scott E; Feng, Felix Y; Lin, Daniel W; Morgan, Todd M; Morgans, Alicia K; Spratt, Daniel E; Taneja, Samir S; Penson, David F.
Afiliação
  • Cooperberg MR; Department of Urology, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA; Department of Epidemiology & Biostatistics, University of California, San Francisco, CA, USA. Electronic address: matthew.cooperberg@ucsf.edu.
  • Carroll PR; Department of Urology, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.
  • Dall'Era MA; Department of Urology, University of California, Davis, Sacramento, CA, USA.
  • Davies BJ; Department of Urology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
  • Davis JW; MD Anderson Cancer Center, Houston, TX, USA.
  • Eggener SE; Department of Surgery, University of Chicago, Chicago, IL, USA.
  • Feng FY; Department of Urology, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA; Department of Radiation Oncology, University of California, San Francisco, CA, USA.
  • Lin DW; Department of Urology, University of Washington and Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Morgan TM; University of Michigan Department of Urology, Ann Arbor, MI, USA.
  • Morgans AK; Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Spratt DE; Department of Radiation Oncology, University of Michigan School of Medicine, Ann Arbor, MI, USA.
  • Taneja SS; NYU Langone Health, New York, NY, USA.
  • Penson DF; Department of Urology, Vanderbilt University School of Medicine, Nashville, TN, USA; Tennessee Valley Health Care System, Nashville, TN, USA.
Eur Urol ; 76(3): 268-272, 2019 Sep.
Article em En | MEDLINE | ID: mdl-31128968
ABSTRACT
We convened a multidisciplinary expert panel to make recommendations on current utility and future research needs for post-diagnosis prostate cancer biomarkers. The San Francisco Consensus Statement reflects on the rapid recent progress achieved, and the substantial work still ahead.
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Biomarcadores Tumorais / Consenso Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Biomarcadores Tumorais / Consenso Idioma: En Ano de publicação: 2019 Tipo de documento: Article